Applications are currently being accepted for the Cancer Research Institute (CRI) Technology Impact Award Grant 2026. Interested applicants are encouraged to click here to learn more about this opportunity and apply for it.
The CRI Technology Impact Award is designed to support high-risk, high-reward technology development in cancer immunotherapy.The programme targets ideas at the earliest stage of development. Rather than funding the routine application of existing technologies, it seeks innovative concepts that could create entirely new technological capabilities for cancer research and treatment.
Selected projects can receive:
Applicants must hold a tenure-track position at a not-for-profit research centre or institution.
The programme encourages interdisciplinary teams, particularly collaborations involving:
Co-principal investigators are eligible to apply, making the programme suitable for collaborative technology-development projects.
Apply for CRI Technology Impact Award Grant